The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kiora Pharmaceuticals, Inc.(NASDAQ:KPRX) 
Kiora Pharmaceuticals, Inc., an ophthalmic specialty pharmaceutical company, develops therapies for the treatment of eye diseases in the United States. Its pipeline includes KIO-101, a small molecule DHODH inhibitor that treats immunologic eye diseases; KIO-201, an eye drop that enhances ocular woun...
Website: http://www.kiorapharma.com
Founded: 1998
CEO: Brian M Strem
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Kiora Pharmaceuticals . Days Payable Outstanding ttm (DPO)
Kiora Pharmaceuticals . Days Receivable Outstanding ttm (DSO)
Kiora Pharmaceuticals . Days Inventory Outstanding ttm (DIO)
Kiora Pharmaceuticals . Op Cashflow Per Share ttm
Kiora Pharmaceuticals . Free Cashflow Per Share ttm
Kiora Pharmaceuticals . Cash Per Share ttm
Kiora Pharmaceuticals . P/S ratio ttm
Kiora Pharmaceuticals . (GAAP) P/E ratio ttm
Kiora Pharmaceuticals . P/B ratio ttm
No extra charts and metrics for this ticker.